A phase II trial of erlotinib as maintenance treatment after concurrent chemoradiotherapy in stage III non-small-cell lung cancer (NSCLC): A Galician Lung Cancer Group (GGCP) study

  1. Casal Rubio, J.
  2. Fírvida-Pérez, J.L.
  3. Lázaro-Quintela, M.
  4. Barón-Duarte, F.J.
  5. Alonso-Jáudenes, G.
  6. Santomé, L.
  7. Afonso-Afonso, F.J.
  8. Amenedo, M.
  9. Huidobro, G.
  10. Campos-Balea, B.
  11. López-Vázquez, M.D.
  12. Vázquez, S.
Journal:
Cancer Chemotherapy and Pharmacology

ISSN: 1432-0843 0344-5704

Year of publication: 2014

Volume: 73

Issue: 3

Pages: 451-457

Type: Article

DOI: 10.1007/S00280-013-2370-Z GOOGLE SCHOLAR

Sustainable development goals